相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Jacob S. Deyell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Post-translational modification of lysine residues in erythrocyte α-synuclein
Ryosuke Amagai et al.
JOURNAL OF BIOCHEMISTRY (2023)
A functional role for alpha-synuclein in neuroimmune responses
Dustin L. Heiden et al.
JOURNAL OF NEUROIMMUNOLOGY (2023)
Targeting α-synuclein post-translational modifications in Parkinson's disease
Jaquelini B. Canever et al.
BEHAVIOURAL BRAIN RESEARCH (2023)
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels
Iris N. Serratos et al.
MOLECULAR NEUROBIOLOGY (2022)
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Md Masud Alam et al.
CELL REPORTS (2022)
Role of glyoxalase 1 in methylglyoxal detoxification-the broad player of psychiatric disorders
Kazuya Toriumi et al.
REDOX BIOLOGY (2022)
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
Azad Farzadfard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Alysa Kasen et al.
NEUROBIOLOGY OF DISEASE (2022)
Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes
Ana Chegao et al.
NPJ PARKINSONS DISEASE (2022)
Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation
Kakuhiro Yamaguchi et al.
RESPIRATORY INVESTIGATION (2022)
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
Andrei Surguchov et al.
BIOMEDICINES (2022)
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease
Seigmund Wai Tsuen Lai et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2022)
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review
Jacopo Pasquini et al.
MOVEMENT DISORDERS (2022)
Interaction of RAGE with a-synuclein fibrils mediates inflammatory response of microglia
Houfang Long et al.
CELL REPORTS (2022)
Advanced Glycation End Products in Health and Disease
V. Prakash Reddy et al.
MICROORGANISMS (2022)
Interactions of α-synuclein oligomers with lipid membranes
Greta Musteikyte et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2021)
Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs
Tapan Behl et al.
MOLECULAR BIOLOGY REPORTS (2021)
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
Sara Konstantin Nissen et al.
MOVEMENT DISORDERS (2021)
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga et al.
MOLECULAR NEURODEGENERATION (2021)
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Dorit Trudler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy
Tim E. Moors et al.
ACTA NEUROPATHOLOGICA (2021)
Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications
Rosie Bell et al.
FRONTIERS IN NEUROLOGY (2021)
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis
Craig D. Hughes et al.
ACTA NEUROPATHOLOGICA (2019)
Systemic Inflammation Changes the Site of RAGE Expression from Endothelial Cells to Neurons in Different Brain Areas
Juciano Gasparotto et al.
MOLECULAR NEUROBIOLOGY (2019)
Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model
Soo Jeong Kim et al.
LABORATORY INVESTIGATION (2019)
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases
Jiaming Zhang et al.
FRONTIERS IN NEUROSCIENCE (2019)
Cellular models of alpha-synuclein toxicity and aggregation
Marion Delenclos et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Gastrointestinal Immunity and Alpha-Synuclein
Denise Barbut et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Enteric alpha-synuclein expression is increased in Crohn's disease
Alice Prigent et al.
ACTA NEUROPATHOLOGICA (2019)
Disruptive membrane interactions of alpha-synuclein aggregates
Aditya Iyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
CRISPR/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinson's Disease Model
Aesuk Lee et al.
INTERNATIONAL JOURNAL OF STEM CELLS (2019)
Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3 beta/beta-Catenin Signaling Pathway
Sasuk Kim et al.
MOLECULAR NEUROBIOLOGY (2018)
AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression
Hyun Jin Cho et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease
Gregory P. Williams et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease
Silke Nuber et al.
NEURON (2018)
Putative model for heat shock protein 70 complexation with receptor of advanced glycation end products through fluorescence proximity assays and normal mode analyses
Marcelo Sartori Grunwald et al.
CELL STRESS & CHAPERONES (2017)
A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
Ethan Stolzenberg et al.
JOURNAL OF INNATE IMMUNITY (2017)
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
Julianna J. Tomlinson et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Yu-Wan Yang et al.
MEDICINE (2017)
Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation
Juciano Gasparotto et al.
SCIENTIFIC REPORTS (2017)
The Synucleinopathies: Twenty Years On
Michel Goedert et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Extracellular HSP70 Activates ERK1/2, NF-κB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells
Nauana Somensi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda et al.
BRAIN (2017)
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin
Nicoletta Plotegher et al.
AGEING RESEARCH REVIEWS (2016)
Presymptomatic MPTP Mice Show Neurotrophic S100B/mRAGE Striatal Levels
Sofia D. Viana et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
Pathways of the Maillard reaction under physiological conditions
Christian Henning et al.
GLYCOCONJUGATE JOURNAL (2016)
Regulation of striatal astrocytic receptor for advanced glycation end-products variants in an early stage of experimental Parkinson's disease
Sofia D. Viana et al.
JOURNAL OF NEUROCHEMISTRY (2016)
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro et al.
NEUROBIOLOGY OF DISEASE (2016)
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
Ulf Dettmer et al.
NATURE COMMUNICATIONS (2015)
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Heather E. Allen Reish et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko et al.
NEUROLOGY (2014)
Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population
Jing Gao et al.
NEUROSCIENCE LETTERS (2014)
The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)
Luca Sessa et al.
PLOS ONE (2014)
Mild exposure of RIN-5F β-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: An hormetic stimulus
Elisabetta Borchi et al.
REDOX BIOLOGY (2014)
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Cherilyn M. Sirois et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
RAGE regulation and signaling in inflammation and beyond
Katrin Kierdorf et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson's Disease
Erika Guerrero et al.
MOLECULAR NEUROBIOLOGY (2013)
Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease
Shyra J. Gardai et al.
PLOS ONE (2013)
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
Kinnari Sathe et al.
BRAIN (2012)
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
Jacqueline Burre et al.
JOURNAL OF NEUROSCIENCE (2012)
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
Peter Teismann et al.
NEUROBIOLOGY OF AGING (2012)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
Alexander Kurz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yasuhiko Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2011)
S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling
Alejandro Villarreal et al.
JOURNAL OF NEUROCHEMISTRY (2011)
TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
Masakiyo Sakaguchi et al.
PLOS ONE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment
Anna Gomez et al.
ACTA NEUROPATHOLOGICA (2010)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains
Estelle Leclerc et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Evidence of oxidative stress in the neocortex in incidental Lewy body disease
E Dalfó et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions
S Chandra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The AGE-RAGE system and diabetic nephropathy
S Sakurai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
D Stern et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Structural transformation and aggregation of human α-synuclein in trifluoroethanol:: Non-amyloid component sequence is essential and β-sheet formation is prerequisite to aggregation
HT Li et al.
BIOPOLYMERS (2002)
Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation?
G Münch et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)